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Abstract.  Transcellular  transport  of a  variety of 
ligands  may be an  important  mechanism  by which 
regulatory  substances  reach  their  site of action.  We 
have studied the transcellular  transport  of two 6,000- 
mol-wt proteins,  epidermal  growth factor (EGF)  and 
insulin,  across polarized  Madin-Darby  canine  kidney 
(MDCK)  cells grown on dual-sided  chambers  on a 
nitrocellulose  filter substrate.  When grown on these 
chambers,  MDCK  cells are polarized  and  express  dis- 
tinct basal  and  apical  surfaces.  MDCK cells are capa- 
ble of unidirectional  transport  of EGF from the basal- 
to-apical  direction,  50%  of bound EGF transported  in 
2  h.  Transport  was inhibited  by the addition  of unla- 
beled EGF in a  dose-dependent  manner.  Anti-EGF 
receptor Ab,  which  inhibited  binding,  also inhibited 
transport.  No transport  in the apical-to-basal  direction 
is noted.  Insulin  transport  is not observed in either 
direction.  Transport  correlates  with the presence  of 
ligand-specific  receptors  on the cell  surface.  Hence, 
EGF  receptors  (Ro  =  48,000,  Kd  =  3.5  X  10  -~~ M) are 
found only on the basal  surface of the MDCK  cells 
and  neither  surface expresses  insulin  receptors.  Char- 
acterization  of the  EGF receptors  on MDCK cells,  as 
assessed by affinity,  molecular  mass,  and  anti-receptor 
antibody binding  reveals that  this  receptor has  similar 
characteristics  to EGF  receptors previously described 
on a  variety of cells.  Hence,  the EGF receptor can 
function  as a  transporter  of EGF across  an  epithelial 
cell barrier. 
T  RANSCVTOSIS  is the term that has been applied to the 
transcellular transport of a variety of ligands including 
immunoglobulins  (24, 25), insulin (13), albumin (7), 
thyroglobulin (9), ferritin (36), nerve growth factor (34), and 
viral  proteins  (28).  Many  of these  ligands  bind  to  high 
affinity receptors known to mediate endocytosis (29, 38). Re- 
cent evidence suggests that a number of cell types can, after 
binding of ligand,  direct the ligand-receptor complex to ei- 
ther a lysosomal degradative pathway or can shuttle the intact 
complex across the cell (37). The mechanism by which trans- 
cytosis occurs is poorly understood, but may involve translo- 
cation of the endocytotic vesicle after internalization.  Such 
a process would require sorting of endocytic vesicles shortly 
after  internalization.  To  further  examine  the  process  of 
receptor-mediated transcytosis of hormones, we have exam- 
ined the ability of a polarized epithelial cell to transport two 
ligands:  epidermal  growth factor (EGF) 1 and insulin. 
The Madin-Darby canine kidney (MDCK) cells are pola- 
rized epithelial cells (4). When grown in culture, the plasma 
membrane is differentiated into an apical surface with micro- 
villi facing the growth medium and a basolateral surface fac- 
ing the neighboring cells and the substratum (16, 23, 30). In 
addition, these structurally and functionally different plasma 
1. Abbreviations  used in this paper:  DSS, disuccinimidyl suberate; EGF, 
epidermal growth factor. 
membrane  domains  are  separated  by tight junctions  (18). 
These cells have been used in both studies of immunoglobu- 
lin transport and in studies of transport and sorting of cellular 
and viral proteins (2,  19-22, 27, 28). EGF is a 6,045-mol-wt 
protein of 53 amino acids with a variety of biological actions 
(3, 5, 32), including stimulation of epidermal and epithelial 
cell proliferation.  Biological activity requires binding of the 
ligand  to  specific plasma  membrane  receptors  which  is  a 
well-characterized  170-185-kD  glycoprotein  with  tyrosine 
kinase activity; after binding,  the ligand-receptor  complex 
is internalized  and the receptor undergoes a tyrosine phos- 
phorylation.  Insulin  is a  51-amino  acid protein  of 5.6  kD 
which binds to a specific plasma membrane receptor (6,  11). 
Similarly, binding is followed by tyrosine autophosphoryla- 
tion of the receptor and the receptor-ligand complex is known 
to be internalized (6, 12). Receptor-mediated transcytosis (13, 
14) of insulin by endothelial cells has been demonstrated and 
is important  in the delivery of insulin  to target tissues. 
Materials and Methods 
Cell Culture 
MDCK cells were  obtained  from the American Type Tissue Collection 
(Rockville, MD). After three passages in our laboratory, a stock of cells was 
frozen. Cells used in this study were between passages 3 and 15. Stock cul- 
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Earle's salts, supplemented with 5% FBS. Cells used in experiments were 
plated directly onto 30-mm surfactant-free 0.45-gm nitrocellulose filters in 
premounted presterilized plastic chambers (Millicell HA: Millipore/Con- 
tinental Water Systems, Bedford, MA). Cells were fed by changing media 
in both the upper and lower chamber compartments and were used in experi- 
ments between 5 and 7 d after plating. The number of cells per well were 
determined by removing cells from the nitrocellulose substrate using 1 ml 
of  0A% trypsin in Ca  ++- and Mg++-free  PBS. Trypsinized cells were added 
to an equal volume of serum containing media and were counted using a 
hemocytometer (Fisher  Scientific Co.,  Medford,  MA).  Cell  number  at 
confluence ranged between 1.8 and 2.0  ￿  106 cells/well. Monolayers were 
examined by electron microscopy (kindly performed by Dr. Susan Bonner- 
Weir). This confirmed that the MDCK cells grew as a single layer of pola- 
rized cells on the membrane. To confirm the presence of tight junctions in 
the MDCK cell monolayer, the effect of 1.0 mM EGTA, which is known 
to disrupt tight junctions, was examined. 1 mM EGTA was added to both 
the basal and apical surface and [12SI]EGF or [14Clinulin were added in the 
apical media. At 60 min, in monolayers treated with EGTA, there was 30 
times as much inulin and EGF on the basal surface. This demonstrates that 
EGTA can disrupt tight junctions and that this will lead to apical -~ basal 
nonreceptor-mediated leakage of ligand. 
Ligands 
Receptor grade EGF was purchased from Collaborative Research Inc. (Bed- 
ford, MA) and iodinated using chloramine T to a specific activity of 194 
~tCi/pg. Monoiodinated HPLC-purified A-14 insulin and [t4C]inulin were 
purchased from Amersham Corp.  (Arlington Heights, IL). 
Binding Studies 
Binding of EGF and insulin was performed on either apical and basal sur- 
faces of MDCK cells  grown on millicell chambers.  For EGF binding, 
growth media from both surfaces was aspirated and both cell surfaces were 
washed three times with cold sterile PBS. Hepes buffer (llg mM NaCl2, 
5 mM KCl,  1.2 mM MgSO4, 10 mM CaCI2, 8.8 mM dextrose, 50 mM 
Hepes,  1% BSA), pH 7.4, was then added to each side. 50,000 cpm of la- 
beled [12~I]EGF was added to either the basal or apical surface. Competi- 
tion curves were derived by adding variable amounts, ranging from 1 ng/ml 
(1.7  x  10  -9 M) to 200 ng/ml (3.4 x  10  -7 M), of unlabeled EGF to the sur- 
face exposed to the labeled ligand. Chambers were incubated at 4~  for 6 h. 
After three washes with cold PBS, filters were cut out of  the chambers using 
a single-edge razor and counted in a multichannel ganm~ counter. Data was 
analyzed using Scatchard analysis. Insulin-binding studies were performed 
similarly, however, the pH of the Hepes buffer was pH ZS, and incubations 
were performed at  15~ 
Ligand Transport 
After aspiration of growth media, each side of the chambers was washed 
three times with PBS, pH 7.4; 1.5 cc of  Hepes buffer was added to the outer 
(basal surface) chamber and 1.0 cc of buffer to the inner (apical surface). 
These different volumes were used in order to have the same level of fluid 
in the inner and outer chamber. 50000 cpm (0.137 ng) of labeled EGF was 
added to either the apical or basal side of the chambers. Chambers were 
incubated at the designated temperature and sampled from the side opposite 
to which the tracer had been added at the designated time points. For sam- 
pling, 500-~tl aliquots wore taken and the volume was replaced with fresh 
buffer. To determine the specificity of  the EGF transport, some studies were 
performed  with varying amounts of unlabeled EGF present.  To exclude 
leakage through a nonconfluent monolayer the transport of 50000  cpm of 
[~C]inulin, added to the side containing the labeled ligand, was examined 
in each chamber studied. Inulin is primarily a marker of the extracellular 
space and diffuses freely across the nitrocellulose membrane. Insulin trans- 
port was studied using the same conditions. 
Cross-linking 
Disuccinimidyl suberate (DSS) was purchased from Pierce Chemical Co. 
(Rockford,  IL),  and  was used to cross-link  [uSI]EGF to MDCK cells. 
[t2~I]EGF was added to either the apical or basal surface of MDCK cells 
grown on two-sided chambers, and incubated for  4 h at 4~  Chambers were 
then washed three times with albumin-free Hepes buffer and cells were 
scraped off the filter using a rubber policeman. Ceils were then suspended 
in 1 mi of albumin-free Hepes in a plastic tissue culture tube. DSS, freshly 
dissolved in DMSO, was added to the cells to a final concentration of 0.5 
mM, and cells were incubated at 15~  for 30 min. Cells were pelleted by 
centrifugation  and the DSS-containing solution was aspirated.  The cells 
were washed three times in 4 ml of solution containing 120 mM NaCI,  10 
mM Tris-HC1, and 1 mM EDTA. Cell pellets were then solubilizexi  in 200 
ltl of Laemmli buffer (15) (2%  SDS, 10% glycerol, 0.002% bremphenol 
blue,  10 mM Na2HPO4 with t5 mg/ml DTr) (14). Samples were analyzed 
by polyacrylamide electrophoresis  on 7.5% acrylamide  gels.  Fixed and 
dried gels were autoradiographed with Kodak X-Omat film for 6 wk. 
Results 
TransceUular Transport 
As the nitrocellulose filter itself is a barrier to the passive 
diffusion of small proteins across the chamber, the kinetics 
of EGF and inulin diffusion across the membrane were ex- 
amined.  Although both molecules  have similar molecular 
masses,  the diffusion of inulin was faster  than that of EGE 
At 2  h (Fig.  1), 45 % of the total inulin added and 22 % of 
the  total  EGF  added  had  diffused  across  the membrane. 
Diffusion of both EGF and inulin was somewhat more rapid 
in the apical-to-basal direction in empty chambers.  Insulin 
diffusion across the membrane at 2  h was  15% of the total 
[12sI]insulin  added  (data  not  shown).  In  contrast,  MDCK 
cell monolayers grown on millicell chambers represented an 
almost absolute barrier to the diffusion of inulin. At 2 h, <1% 
of the inulin had diffused across the chamber. When labeled 
EGF was added to the basal surface of the cell monolayer, 
~  % of the total tracer added appeared on the apical surface 
within 120 min (Fig.  1). This data suggested that EGF might 
be actively transported across the cell monolayer. 
To  characterize  the  ability  of MDCK  cells  to  actively 
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Figure  L  Transport  dynamics  of  chambers.  [~C]Inulin  or 
[12SI]EGF (~o50,000  cpm) were added to the outer chamber of ei- 
ther empty chambers or MiUiccll chambers containing a confluent 
monolayer of MDCK cells. The inner chamber was sampled at 30- 
min intervals; 0.1-ml samples of  transport buffer were taken and the 
volume was replaced with an equal volume of fresh buffer. Percent 
transported was calculated by determining total cumulative amount 
of tracer appearing on the inner chamber as a percentage of  the total 
tracer added. 
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Figure 2.  Ligand transport.  [14C]- 
Inulin and either [t~I]EGF or [t~I]- 
insulin  were added to either the 
apical or basal surface of MDCK 
cells grown on chambers.  At 30- 
rain intervals samples were taken 
from  the  opposite  surface,  and 
replaced with an equal volume of 
fresh  transport  buffer.  Percent 
ligand  transported  was  deter- 
mined by calculating  total cumu- 
lative counts transported as a per- 
cent  of the  total  tracer  added. 
Each point represents the mean of 
three  chambers  and  error  bars 
show SD. 
transport hormones across the cell monolayer, basal-to-api- 
cal and apical-to-basal transport of inulin, EGF, and insulin 
across the MDCK monolayers were evaluated.  2 h after the 
addition of [14C]inulin  to either the basal or apical surface 
of the chamber,  a  total of 1%  of the total inulin added ap- 
peared  in the contralateral  surface (Fig.  2).  As inulin  is a 
marker of the extracellular  space and is not actively trans- 
ported via a receptor-mediated process, the appearance of in- 
ulin  on  the  contralateral  surface  was  considered  passive 
diffusion across the cell monolayer. When EGF was added 
to the basal surface, the appearance of labeled growth factor 
on the apical  surface was time dependent. 
Over 120 min,  the amount of tracer increased in a linear 
fashion, after an initial 30-min lag period. At 120 min, 3.2 % 
of the total tracer added to the basal surface had appeared on 
the apical surface. In contrast, when EGF was added to the 
apical  surface,  less  than  1%  of the total  tracer  added  ap- 
peared in the lower chamber.  Whereas the amount of EGF 
transported in the basal-to-apical direction was three times 
higher  than  the  diffusion  of inulin  in  the  basal-to-apical 
direction,  the amount of EGF transported in the apical-to- 
basal direction was equal to the amount of inulin diffusing 
in the apical-to-basal  direction.  Hence,  active transport  of 
EGF was unidirectional in MDCK cells grown in dual-sided 
chambers.  We next examined the ability of MDCK cells to 
transport  insulin.  The  appearance  of insulin  on  the  con- 
tralateral  side paralleled  the appearance of inulin,  and did 
not exceed  1%  of the total tracer added at  120 rain.  Hence, 
insulin  was  not  transported  in  either  direction  by MDCK 
cells  (Fig.  2)  when  added  to  either  the  basal  or  apical 
surface. 
To determine the mechanism by which EGF might be pref- 
erentially  transported  in  the  basal-to-apical  direction,  the 
ability of MDCK cells to bind EGF and insulin to the basal 
and apical surfaces was evaluated.  EGF added to the basal 
surface of the MDCK cells bound in a specific and saturable 
fashion.  At 4~  binding was maximal within 4 h  and was 
6.5 % of the total tracer added. Binding could be inhibited by 
the addition of increasing amounts of cold unlabeled EGF at 
concentrations  between  1  ng/ml  (1.7  x  10  -9  M)  and  200 
ng/ml  (3.4  x  10  -7 M)  as  seen  in Fig.  3.  Using Scatchard 
analysis (31) a linear Scatchard curve was generated. MDCK 
cells were found to have 48,000 EGF receptors with a Kd of 
3.5  X  10  -1~ M  on the basal surface.  Substantially less bind- 
ing was detectable on the apical surface of the MDCK cells. 
Less than  1%  of the total tracer added bound to the cells; 
while some inhibition of binding was seen with a large excess 
of tracer EGF, the total binding of 0.8 %  was so low that a 
meaningful Scatchard could not be generated.  Nonspecific 
binding of 125EGF to empty chambers was  1.0-1.5%  of the 
total tracer added.  This binding is equal to the nonspecific 
binding of EGF (not inhibitable by 200 ng/ml of unlabeled 
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Figure 3. EGF-binding studies. 50,000 cpm of iodinated EGF were 
added to either the apical or the basal surface of MDCK cells. For 
the competition curve, binding studies were performed in the pres- 
ence of cold EGF ranging between  1 and 200 ng/ml.  Wells were 
incubated for 6 h at 4~  After incubation,  both the apical and basal 
surfaces  were washed with cold PBS. Filters  were detached from 
chambers using a razor, and counted in a gamma counter. Approxi- 
mately 6% of the tracer bound to the basal  surface.  This binding 
was 50%  inhibited by 5 ng/ml of cold EGE Binding to the apical 
surface was significantly  lower;  less than 1% of the tracer bound. 
Analysis of Scatchard plot in the inset revealed 48,000 receptors per 
cell with a Ks of 3.5  x  10  -~~ M on the basal  surface of the cells. 
Binding on the apical  surface  was so low that a meaningful Scat- 
chard could not be derived. 
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beled  tracer  was  added to either  the basal  or apical  surface of 
MDCK cells grown on chambers.  Cells were then incubated for 4 h 
at 4~  Chambers were washed  with cold PBS and scraped from 
the chamber using a rubber policeman. Cells were suspended in 
Hepes binding buffer (without BSA) containing the cross-linked  re- 
agent DSS for 30 min. Cells were collected by centrifugation,  solu- 
bilized  in Laemmli buffer. Samples  were subjected  to PAGE over 
7.5 % gels. After fixing and drying, gels were autoradiographed.  On 
the left is the sample taken from cells exposed to EGF on the apical 
surface.  The right lane shows sample  from the basal  surface.  In 
this lane a 185-kD band corresponding to the molecular mass of the 
EGF receptor is visualized. 
EGF) to the basal surface of  MDCK cells, which we attribute 
to trapping of label in the nitrocellulose  filter. 
The presence of EGF receptors on the basal but not apical 
surface of MDCK cells was also confirmed by cross-linking 
radiolabeled  EGF  to  its  receptor  using  the  reagent  DSS. 
Iodinated EGF was added to either the basal or apical surface 
of the MDCK cells and exposed to cross-linking reagents as 
described in Materials and Methods. As can be seen in Fig. 
4,  labeled EGF added to the basal  surface could be cross- 
linked to a 185-kD protein. This is the same as the molecular 
mass of the EGF receptor in a number of cells. We failed to 
detect binding of insulin to either the basal or the apical sur- 
face of the MDCK cells confirming the absence of insulin re- 
ceptors on MDCK cells as has been previously reported (10). 
Specific transport of EGF by MDCK cells in the basal-to- 
apical direction correlated with the presence of high affinity 
EGF receptors on the basal but not the apical surface of the 
cells. MDCK cells do not express insulin receptors on either 
the basal or the apical surface and no transport of insulin was 
noted in either direction.  These data suggest that the trans- 
port of EGF is a  receptor-mediated  process. 
We, therefore,  expected that specific transport of EGF in 
the basal-to-apical direction should be inhibited by the addi- 
tion of cold EGE Transport studies in the presence of 0.85 
nM,  17 nM, and 110 nM of unlabeled EGF were performed. 
As can be seen in Fig.  5, increasing amounts of unlabeled 
EGF in the transport buffer led to decreased transcytosis of 
labeled  EGE  At  110 nM,  active transcytosis of EGF  was 
completely inhibited. We also evaluated the abilty of a large 
excess of  cold EGF to affect transcytosis of EGF in the basal- 
to-apical direction.  110 nM cold EGF had no effect on the 
transc~tosis of labeled EGF in the apical-to-basal direction. 
Antibodies directed against the EGF receptor can inhibit 
binding of EGF to the receptor. One such antibody was avail- 
able to us (kindly provided by Dr. S. Cohen). This antibody 
inhibited binding of EGF to MDCK cells at a  1:100 dilution. 
At the same dilution,  it also inhibited the transport of EGF 
across the MDCK cell monolayer as can be seen in Fig. 6. 
Next, the temperature dependence of the transcytosis was 
evaluated. Tracer EGF was added to cell monolayers on Mil- 
licell  chambers at 4~  Immediately after addition,  cham- 
bers were incubated at 4,  15, or 37~  As can be seen in Fig. 
7,  transport  of EGF  was markedly  decreased  at  15~  and 
even further decreased at 4~ 
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Figure 5. Effect of  cold EGF on 
transport.  Transport  studies 
were performed as described 
in Materials  and Methods in 
the presence of various  con- 
centrations  of unlabeled  EGE 
(Lej~) Addition of cold EGF at 
a concentration of 0.85 nM (5 
ng/ml) led to a substantial de- 
crease  in  transport  of tracer 
EGE  More  inhibition  was 
noted in the presence of 17 and 
100 nM EGE In contrast, ad- 
dition of cold EGF at a con- 
centration of 110 nM had only 
a minimal  inhibitory  effect on 
transport  in the apical-to-basal 
direction,  and this  difference 
was  not  statistically  signifi- 
cant (right). 
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Figure 6.  Effect  of anti-receptor antibody on  EGF transcytosis. 
Transport of tracer EGF was examined in the presence and absence 
of anti-EGF receptor antibody. Antibody, at a dilution of 1:100, was 
added to the basal surface of cells and preincubated for 60 min at 
37~  Tracer EGF was then added and samples were taken at 30- 
min intervals over 4.5 h. Each point represents the mean of tripli- 
cate wells and bars show the SD. Anti-receptor antibody inhibited 
transport by 70%. 
To ensure that EGF transported across MDCK cells was 
intact,  we  examined  tracer  EGF  using  Sephadex  column 
chromatography over a G-25 column. As can be seen in Fig. 
8, the elution pattern of EGF tracer collected from the upper 
chamber after a transport experiment did not differ markedly 
from the elution pattern of control EGF tracer that had not 
been  exposed  to  MDCK  cells.  In  each  case,  intact  EGF 
eluted in fractions 13-16 and degraded EGF eluted in the void 
volume. To calculate the percent of tracer degraded, we com- 
pared the area under the curve of the two peaks. For control 
EGF, the tracer was 89 % intact and for the transported EGF 
the tracer was 78 %  intact. Hence, the tracer transported by 
the MDCK  cells remains essentially intact. 
We also compared the relative quanitities of tracer EGF 
bound and  transported by the basal surface of the MDCK 
cells.  ['ZH]EGF was  bound to the basal surface of MDCK 
cells for 2.5 h at 4~  Unbound tracer was removed by wash- 
ing three times with 1 ml of Hepes buffer. Fresh buffer was 
then added to each chamber and chambers were transferred 
to 37~  and sampled as described. EGF appeared at the api- 
cal surface within  15 min of warming.  The amount of EGF 
transported, as can be seen in Fig. 9, was ~30% of the total 
tracer specifically bound to MDCK cells. 
Discussion 
Increasingly, transcellular transport of a variety of ligands is 
being  recognized as  an  important  mechanism  by  which  a 
number of regulatory substances may reach their site of ac- 
tion (7, 9,  13, 24, 25, 34, 36). In specialized tissues such as 
the brain and the thyroid, transcytosis is the mechanism by 
which hormones and metabolic factors may enter and/or be 
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Figure 7. Temperature dependence of EGF transport. Transport of 
EGF from the basal to the apical surface was evaluated at 37,  15, 
and 4~  Samples were taken as described. Each point represents 
the mean from triplicate wells and bars show the SD. Transport was 
temperature dependent.  Cooling  samples to  15~  almost  com- 
pletely inhibited the  translocation from  the  basal to  the  apical 
surface. 
100 
80 
"7 
o  60 
X 
40 
20 
0  I  I 
s  10 
TRANSPORTED EGF 
CONTROL TRACER 
i  i  i  L 
15  20  25  30  35 
FRACTION  NUMBER 
J 
40 
Figure 8. Analysis of degradation of transported tracer. Transport 
studies were performed under usual conditions except that 500,000 
cpm was added to the basal surface. After a 2-h incubation at 37~ 
counts  were  collected from the  apical surface and  subjected to 
column chromatography over a Sephadex G-50 column. The elu- 
tion pattern of transcytosed EGF was compared with the elution 
pattern of tracer EGF not exposed to cells. In both cases, intact EGF 
eluted between fractions 12 and 15 and degraded EGF eluted in the 
void volume, fractions 26-35. Analysis  of the area under the curves 
revealed that 89.5 % of the control tracer and 78%  of the transcy- 
tosed tracer eluted as intact EGE 
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Figure 9.  Relative proportion of bound EGF that is transported. 
Tracer EGF was added to the basal surface of MDCK cells and al- 
lowed to bind for 2.5 h at 4~  At the end of this incubation, the 
basal surface was washed three times with cold PBS to remove un- 
bound EGE Chambers were warmed to 37~  and sampled at desig- 
nated intervals over a 3-h period. Total EGF bound in this experi- 
ment was 10,222 cpm with a range of 587 cpm. Total transported 
at 3 h was 3,180 with a range of 400 cpm. 
cleared from the systemic circulation (9, 36). While transcel- 
lular transport is likely to be an important physiologic pro- 
cess, the general nature of this phenomenon and the mecha- 
nism by which it occurs is not yet understood. 
In this report, EGF was shown to be transported across the 
MDCK cells unidirectionally via a receptor-mediated pro- 
cess  demonstrating that the  EGF hormone receptors can 
function as transporters of  hormones across an epithelial cel- 
lular barrier.  The EGF receptors in the MDCK cells had 
similar binding affinities and molecular size as those previ- 
ously reported in a variety of cells and can be recognized by 
antibody made against EGF receptors of another cell line (3, 
5, 32). Similarly, we have previously shown that insulin may 
be transported in endothelial cells and that the endothelial 
cell insulin receptor has a similar molecular mass and sub- 
unit structure and tyrosine kinase as the adipocyte insulin 
receptor (6,  11,  12). 
After binding ofa ligand to its membrane receptor, ligand- 
receptor complexes are internalized rapidly. Once internal- 
ized via endocytotic vesicles, there appear to be a number 
of  possible pathways for processing of  the hormone-receptor 
complex. These pathways include targeting to lysosomes, re- 
cycling (33, 35), and transcytosis. Analysis of  these pathways 
is complex as the hormone-receptor  complex may remain in- 
tact or may dissociate. In this study,  we have demonstrated 
that epidermal growth factor can be shunted via a transcytotic 
pathway. Similarly,  when insulin and insulin-like growth fac- 
tor are added to endothelial cells most of the internalized 
ligand is transported across the cell while a minor compo- 
nent is degraded. Multiple pathways  may not be unique for 
these types of cells and may exist in all cells; however, the 
quantitative  dynamics of hormone traffic in  the  different 
pathways may vary greatly. For example, the existence of a 
dual pathway for the processing of insulin in adipocytes has 
been demonstrated (17); however, in contrast to endothelial 
cells most of the internalized insulin is degraded and only a 
small fraction of the hormone is recycled undegraded. In ad- 
dition, the sorting pathway is dependent on both the cell type 
and the ligand; e.g., we have shown that a large percent of 
insulin-like  growth  factor-II was  degraded  in  endothelial 
cells, whereas insulin was not (8). While it has been postu- 
lated that serine phosphorylation of receptors may signal in- 
ternalization  (1,  26),  the  mechanism by which  endocytic 
vesicles might be channeled via different pathways  is un- 
known and it is unclear if the pathways  involve continuous 
coupling of the hormone to the receptor. 
EGF receptors are internalized rapidly and can be targeted 
for recycling or degradation or transcellular transport. Using 
the data from Scatchard analysis (Fig. 3) and the amount of 
EGF transported (Fig. 9) we calculated that the rate at which 
EGF is transported over the initial 30 min of the experiment 
is 1.5  x  107 EGF molecules per min. This amount of trans- 
port is certainly compatible with a receptor-mediated mech- 
anism as there are 9.6  x  10  t~ receptors per well available 
for transport. 
In  addition  to  demonstrating  that  EGF  transcytosis  in 
MDCK cells is a receptor-mediated process, these data also 
show that the transport process is unidirectional, as has been 
seen for insulin in endothelial cells (13) and IgA secretory 
protein in MDCK cells (24, 25). The mechanism appears to 
be  an  uneven distribution  of EGF  receptors between  the 
basal and apical plasma membrane. Binding and cross-link- 
ing studies revealed that most, if not all, of the EGF recep- 
tors are located on the basal surface suggesting that MDCK 
cells sort EGF receptors to the basal surface, a finding which 
is consistent with the known polarity of MDCK cells grown 
on dual-sided chambers (16, 23, 30). Such a mechanism for 
unidirectional transport might operate in other cells, such as 
endothelial cells. It is unclear if during transcytosis the hor- 
mone-receptor complex dissociates  intracellularly and  if 
receptor fusion at the apical surface is necessary. 
Hence, specific transport of EGF by MDCK cells in the 
basal-to-apical direction correlated with the presence of high 
affinity EGF receptors on the basal but not the apical surface 
of the cells. MDCK cells do not express insulin receptors on 
either the basal or the apical surface and no transport of insu- 
lin was noted in either direction. These data suggest that the 
transport  of EGF  is  a  receptor-mediated process and  the 
mechanism for the unidirectional transport is due to sorting 
of EGF receptors to the basal surface. 
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